MitraGen is developing a unique and compelling transcatheter mitral valve repair (TMVR) technology that has been validated in published pre-clinical studies. MitraGen’s technology and devices will allow the interventional cardiologist to remodel a dilated mitral valve annulus, in a conventional cardiac cath lab procedure, improving leaflet coaptation and reducing mitral regurgitation.
Key to MitraGen’s technology and clinical approach are:
Femoral vein access and conventional septal crossing, consistent with other interventional procedures.
- Steerable therapy delivery device is passed into the left atrium and positioned on the posterior annulus using TEE and Fluoroscopy guidance.
- Thermal Remodeling of Collagen (TRC) is used to treat the mitral valve annulus from trigone to trigone, shrinking and remodeling the valve annulus naturally and permanently.
- Collagen shrinkage and valve remodeling are immediate allowing confirmation of therapy effectiveness during the procedure.
- When the procedure has been completed the therapy delivery device is removed
No hardware is left in the heart or vascular system